Polaryx Therapeutics Inc (PLYX)

$4.85 -0.47 (-8.83%)
Market Cap 250.20M
Revenue (ttm) 0.00
Net Income (ttm) -8.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 89,400
Avg Vol 2,231,844
Day's Range N/A - N/A
Shares Out 47.03M
Stochastic %K 2%
Beta N/A
Analysts Strong Sell
Price Target $10.00

Company Profile

Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage n...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 940 7236
Website: polaryx.com
Address:
South Tower, 140 E Ridgewood Avenue Suite 415, Paramus, United States
lambyjams
lambyjams Apr. 24 at 4:13 PM
$PLYX FDA fast track for their lead candidate. -15%. Makes sense. What a stupid market.
1 · Reply
MurrayK
MurrayK Apr. 24 at 4:08 PM
$PLYX not looking good. Likely see a slow fade here without a catalyst
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 24 at 3:33 PM
$PLYX good place to buy
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 23 at 9:33 PM
$ANNA $SST $AIFF $PLYX $EDSA ANNA time?
1 · Reply
SuperGreenToday
SuperGreenToday Apr. 23 at 6:31 AM
$PLYX
1 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 22 at 7:56 PM
$SST $ANNA $AIFF $PLYX $EDSA not one new ticker since April 1st that meets my epic criteria...at least we've got these beauts to play with #greatagain
0 · Reply
permabull869
permabull869 Apr. 22 at 4:17 PM
$PLYX what’s the next catalyst?
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 21 at 8:10 PM
$SST (looks primed) $ANNA $AIFF $PLYX $EDSA
0 · Reply
permabull869
permabull869 Apr. 21 at 4:06 PM
$PLYX this will be slow and steady over few days.
0 · Reply
oldwisetrader
oldwisetrader Apr. 21 at 3:18 PM
$PLYX if volume kicks in, it will run back to pre market levels
0 · Reply
Latest News on PLYX
Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference

Apr 23, 2026, 8:30 AM EDT - 2 days ago

Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

Apr 21, 2026, 8:30 AM EDT - 4 days ago

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care

Apr 15, 2026, 9:15 AM EDT - 10 days ago

Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care

Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference

Apr 1, 2026, 8:30 AM EDT - 24 days ago

Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)

Mar 17, 2026, 8:30 AM EDT - 5 weeks ago

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)

Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events

Mar 12, 2026, 8:30 AM EDT - 6 weeks ago

Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events

Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders

Feb 27, 2026, 8:30 AM EST - 2 months ago

Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders

Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans

Feb 17, 2026, 10:26 AM EST - 2 months ago

Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans

Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial

Feb 17, 2026, 8:30 AM EST - 2 months ago

Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial

Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™

Feb 10, 2026, 8:30 AM EST - 2 months ago

Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™

Polaryx Therapeutics Welcomes New Members of the Board of Directors

Feb 5, 2026, 8:30 AM EST - 2 months ago

Polaryx Therapeutics Welcomes New Members of the Board of Directors

Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch

Feb 3, 2026, 8:30 AM EST - 2 months ago

Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch

Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”

Feb 2, 2026, 8:30 AM EST - 2 months ago

Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”

Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq

Jan 30, 2026, 8:00 AM EST - 3 months ago

Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq

lambyjams
lambyjams Apr. 24 at 4:13 PM
$PLYX FDA fast track for their lead candidate. -15%. Makes sense. What a stupid market.
1 · Reply
MurrayK
MurrayK Apr. 24 at 4:08 PM
$PLYX not looking good. Likely see a slow fade here without a catalyst
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 24 at 3:33 PM
$PLYX good place to buy
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 23 at 9:33 PM
$ANNA $SST $AIFF $PLYX $EDSA ANNA time?
1 · Reply
SuperGreenToday
SuperGreenToday Apr. 23 at 6:31 AM
$PLYX
1 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 22 at 7:56 PM
$SST $ANNA $AIFF $PLYX $EDSA not one new ticker since April 1st that meets my epic criteria...at least we've got these beauts to play with #greatagain
0 · Reply
permabull869
permabull869 Apr. 22 at 4:17 PM
$PLYX what’s the next catalyst?
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 21 at 8:10 PM
$SST (looks primed) $ANNA $AIFF $PLYX $EDSA
0 · Reply
permabull869
permabull869 Apr. 21 at 4:06 PM
$PLYX this will be slow and steady over few days.
0 · Reply
oldwisetrader
oldwisetrader Apr. 21 at 3:18 PM
$PLYX if volume kicks in, it will run back to pre market levels
0 · Reply
MurrayK
MurrayK Apr. 21 at 2:33 PM
$PLYX well this isn’t going quite as planned. WTH man!
1 · Reply
oldwisetrader
oldwisetrader Apr. 21 at 2:17 PM
$PLYX above 5.80 should run
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 21 at 1:49 PM
$PLYX quite the spike there
0 · Reply
permabull869
permabull869 Apr. 21 at 1:47 PM
$PLYX needs more traffic. News is great.
0 · Reply
kim46
kim46 Apr. 21 at 1:12 PM
$PLYX Strong Strong buyout candidate
0 · Reply
permabull869
permabull869 Apr. 21 at 1:03 PM
$PLYX FDA fast track designation. Let’s see 7 today
0 · Reply
DekmarTrades
DekmarTrades Apr. 21 at 12:32 PM
$PLYX Receives U.S. FDA Fast Track
0 · Reply
Stock_Catcher
Stock_Catcher Apr. 21 at 12:30 PM
$PLYX Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 20 at 10:04 PM
$ANNA $SST $AIFF $PLYX $EDSA I like ANNA for taco tuesday... good value imo
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 20 at 4:50 PM
$PLYX buy buy buy the low
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 20 at 1:52 PM
$SST $ANNA $AIFF $EDSA $PLYX break out the good shit... make america green again
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 20 at 1:07 AM
$SST $ANNA $AIFF $EDSA $PLYX
0 · Reply